SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017952
Filing Date
2019-05-09
Accepted
2019-05-09 16:03:55
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aveo-10q_20190331.htm 10-Q 2387874
2 EX-31.1 aveo-ex311_7.htm EX-31.1 16535
3 EX-31.2 aveo-ex312_8.htm EX-31.2 16535
4 EX-32.1 aveo-ex321_9.htm EX-32.1 4473
5 EX-32.2 aveo-ex322_6.htm EX-32.2 4470
  Complete submission text file 0001564590-19-017952.txt   9973687

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aveo-20190331.xml EX-101.INS 2361286
7 XBRL TAXONOMY EXTENSION SCHEMA aveo-20190331.xsd EX-101.SCH 68134
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20190331_cal.xml EX-101.CAL 43492
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20190331_def.xml EX-101.DEF 286783
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20190331_lab.xml EX-101.LAB 523900
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20190331_pre.xml EX-101.PRE 424663
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617- 531-2130
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 19810427
SIC: 2834 Pharmaceutical Preparations